Effects of orelabrutinib, a BTK inhibitor, on antibody-mediated platelet destruction in primary immune thrombocytopenia奥列鲁替尼(orelabrutinib),一种BTK抑制剂,对原发性免疫性血小板减少症中抗体介导的血小板破坏的影响BRITISH JOURNAL OF HAEMATOLOGYIF3.82025-03-110PRE